MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

DIAGNOSTIC PATHOLOGY

Svoboda, M; Sana, J; Redova, M; Navratil, J; Palacova, M; Fabian, P; Slaby, O; Vyzula, R, 2012: MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. DIAGNOSTIC PATHOLOGY 7, p. 31 - 35, doi: 10.1186/1746-1596-7-31

Research Groups:

• Molecular Oncology - Solid Cancer - Ondřej Slabý

CEITEC authors:

• Prof. Ondřej Slabý, Ph.D.